Adopting the TGF-β1 inhibitor pirfenidone, TNF-α inhibitor pentoxifylline, and monocytes depressor clodronate-loaded liposomes, we demonstrated that inhibition of inflammatory action ameliorated HSCs activation and liver fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.